Capecitabine in the treatment of metastatic colorectal cancer.

被引：0
|
作者：
Brockmann, B [1 ]
Magacz, A [1 ]
Bierig, S [1 ]
Kraube, K [1 ]
机构：
[1] Onkol Klin Humaine, Dresden, Germany
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
239
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [21] Oral capecitabine in metastatic colorectal cancer (CRC)
    Basu, B
    Abraham, J
    Bulusu, VR
    Grant, K
    Corcoran, M
    Shaw, J
    Harris, R
    Corrie, P
    Wilson, CB
    BRITISH JOURNAL OF CANCER, 2002, 86 : S47 - S47
  • [22] Temozolimide and capecitabine in patients with refractory KRAS wildtype metastatic colorectal cancer. A phase II trial
    Qvortrup, C.
    Keldsen, N.
    Andersen, F.
    Jensen, H. A.
    Krogh, M.
    Vestermark, L. W.
    Bjerregaard, J. K.
    Pfeiffer, P.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] A phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory metastatic colorectal cancer.
    Overman, Michael J.
    Eng, Cathy
    Kee, Bryan K.
    Fogelman, David R.
    Fark, Christine
    Hippert, Rick
    Holter, Scott
    Issa, Jean-Pierre
    Hamilton, Stanley R.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [24] ORAL TREATMENT OF METASTATIC COLORECTAL CANCER WITH CAPECITABINE: WHAT FACTORS DETERMINE TREATMENT CHOICE?
    Krzemieniecki, K.
    Garbaczonek, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 147 - 147
  • [25] Capecitabine monotherapy for elderly patients with metastatic breast cancer.
    Minea, LN
    Stanculeanu, DL
    Cringeanu, A
    Anghel, RM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 76S - 76S
  • [26] A Phase II open-label study of capecitabine in combination with irinotecan as first-line treatment for metastatic colorectal cancer.
    Cartwright, TH
    Lopez, T
    Vukelja, SJ
    Encarnacion, C
    Boehm, KA
    Asmar, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 284S - 284S
  • [27] A phase II study of oxaliplatin, capecitabine and bevacizumab in the treatment of metastatic colorectal cancer
    Hurwitz, H
    Fernando, N
    Yu, DH
    Morse, M
    Blobe, G
    Gockerman, J
    Odogwu, L
    Mahon, M
    Truax, R
    Franklin, A
    ANNALS OF ONCOLOGY, 2005, 16 : 285 - 285
  • [28] Capecitabine maintenance chemotherapy in the treatment of metastatic colorectal cancer: A meta-analysis
    Ong, B.
    Rocimo, A.
    King, R.
    Yasay, E.
    ANNALS OF ONCOLOGY, 2022, 33 : S298 - S298
  • [29] Capecitabine in combination with panitumumab is not the treatment of choice in older patients with metastatic colorectal cancer
    Liposits, Gabor
    Pfeiffer, Per
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (01) : 114 - 115
  • [30] Burden of illness in metastatic colorectal cancer.
    Neuberger, Edward
    Schwartz, Naomi
    Hsu, Ling-I
    Dillon, Allison
    Siadak, Muriel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 53 - 53
12345